Dopamine Receptor Availability in ADHD

Abstract

Striatal dopamine (D2) receptor availability was determined by iodobenzamide brain SPECT, before and 3 months after methylphenidate (MPH) therapy, in 9 children (mean age, 9.8 years) with attention deficit hyperactivity disorder (ADHD) examined at Gazi University, Ankara, Turkey.

Keywords

• striatal dopamine
• methylphenidate
• attention deficit hyperactivity disorder